Sodium-Glucose Cotransporter 1 (High Affinity Sodium-Glucose Cotransporter or Solute Carrier Family 5 Member 1 or SGLT1 or SLC5A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Calcium Activated Neutral Protease (Calpain or CANP or CAPN or EC 3.4.22.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Bifunctional Epoxide Hydrolase 2 (Cytosolic Epoxide Hydrolase 2 or Epoxide Hydratase or Soluble Epoxide Hydrolase or Lipid Phosphate Phosphatase or EPHX2 or EC 3.3.2.10 or EC 3.1.3.76) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Solute Carrier Family 12 Member 2 (Basolateral Na-K-Cl Symporter or Bumetanide Sensitive Sodium (Potassium) Chloride Cotransporter 1 or SLC12A2 or NKCC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Smoothened Homolog (Protein Gx or SMO) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update